Home › NDC Lookup › RxCUI directory › RxCUI 204874

Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Suspens... — RxCUI 204874

RxNorm drug concept · Semantic clinical drug
RxCUI 204874 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI204874
Official nameHydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashydrocortisone 1 % / neomycin (neomycin sulfate) 0.35 % / polymyxin B (polymyxin B sulfate) 10,000 UNT/ML Ophthalmic Suspension; neomycin sulfate 0.35 % / polymyxin B sulfate 10,000 UNT/ML / hydrocortisone 1 % Ophthalmic Suspension
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)1,270 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is used as add-on treatment for ulcerative colitis, especially when it affects the lower or left side of the colon. It is meant to be used along with other supportive measures y...
  • It's usually used once at night. Lie on your left side while you use it and for about 30 minutes after. Try to hold it in at least an hour, ideally all night. Your doctor may sugge...
  • How do I use it, and how long do I keep it in?
  • A usual course is about 21 days, or until you're in remission. Many people feel better within 3 to 5 days. If you use it longer, your doctor will taper you off to every other night...
📖 Read our full Hydrocortisone Rectal guide →

🕸️ Concept Web — How Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / p... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Suspension RxCUI 204874

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Hydrocortisone 5492
    • Neomycin 7299
    • Polymyxin B 8536
    • Hydrocortisone / neomycin / polymyxin B 217627
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydrocortisone / neomycin / polymyxin B Ophthalmic Suspension 374762
    • Hydrocortisone / neomycin / polymyxin B Ophthalmic Product 1163422
    • Ophthalmic Suspension 316964
    • Ophthalmic Product 1151135
  3. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Hydrocortisone 10 MG/ML 316057
    • Neomycin 3.5 MG/ML 316332
    • Polymyxin B 10000 UNT/ML 316526

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydrocortisone 10 MG/ML SCDC · 316057
  • Neomycin 3.5 MG/ML SCDC · 316332
  • Polymyxin B 10000 UNT/ML SCDC · 316526
  • Hydrocortisone / neomycin / polymyxin B Ophthalmic Suspension SCDF · 374762
  • Hydrocortisone / neomycin / polymyxin B Ophthalmic Product SCDG · 1163422

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 204874 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61314-0641-75 7.5 mL in 1 BOTTLE, PLASTIC (61314-641-75) Neomycin and Polymyxin B Sulfates and Hydrocortisone Sandoz Inc 2003-05-09
Observed labelers: Sandoz Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$18.4420
Range $18.4420–$18.4420 · middle 50% $18.4420–$18.4420 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.